Chimerix Inc. buy Quitte
Start price
06.03.16
/
50%
€4.66
Target price
23.02.17
€6.22
Performance (%)
5.22%
End price
23.02.17
€4.91
Summary
This prediction ended on 23.02.17 with a price of €4.91. The BUY prediction by Quitte finished with a performance of 5.22%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Chimerix Inc. | -7.204% | -7.204% | -24.303% | -86.081% |
| iShares Core DAX® | -3.935% | -3.998% | 11.192% | 10.824% |
| iShares Nasdaq 100 | -3.608% | -9.386% | 22.243% | 34.145% |
| iShares Nikkei 225® | -4.513% | -8.017% | 5.961% | 2.360% |
| iShares S&P 500 | -2.607% | -4.265% | 21.865% | 36.823% |
Comments by Quitte for this prediction
In the thread Chimerix Inc. diskutieren
high risk, high fun?
Die Analysten mögen die Aktie nicht, hat auch seinen Grund. ..
beim Affenwettbewerb sehen das manche anders
Before today's market open, the Durham, NC-based biopharmaceutical company posted a net loss of 82 cents per share, wider than the loss of 73 cents per share that analysts were expecting.
(Laufzeit überschritten)